Value proposition

We are committed to elevating and redefining the standard of care for Obstructive Sleep Apnea.

Inspire Medical Systems, Inc. has developed the world’s first fully implanted neurostimulation device approved by the FDA for the treatment of Obstructive Sleep Apnea (OSA). The Inspire system uses well-established neurostimulation technologies and incorporates a proprietary algorithm that stimulates key airway muscles based on a patient’s unique breathing patterns. Inspire therapy is designed to reduce OSA severity and improve quality of life for patients living with this challenging condition.

Obstructive Sleep Apnea, ENT, sleep, patient engagement, digital health, medical device, medical devices, Sleep Apnea, Healthcare, health systems, and sleep disorders